Journal article · 2023 · Open access

A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes

Sabrina I. Green, Justin R. Clark, Haroldo Hernandez Santos, Kyle Weesner, Keiko Christine Salazar, Saima Aslam, J William Campbell, Sarah B. Doernberg, Emily Blodget, Michele Ileana Morris, Gina Ann Suh, Karam M. Obeid and 6 more

Clinical Infectious Diseases, 77(8), 1079–1091 · Published 3 June 2023 · DOI 10.1093/cid/ciad335

Free PDFView at the publisherCite this paper

In brief

“A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes” is a 2023 journal article by Sabrina I. Green and 17 co-authors, published in Clinical Infectious Diseases. OpenAlex counts 118 citations as of 15 November 2026, which puts it in the top 2% of works published in 2023 by citations. It is open access: the full text is free to read at Clinical Infectious Diseases.

Citations
118
Most cited in
2026 (49)
Field-weighted impact
11.39
References
30
Authors
18

Abstract

BACKGROUND: Antimicrobial resistance (AMR) is undermining modern medicine, a problem compounded by bacterial adaptation to antibiotic pressures. Phages are viruses that infect bacteria. Their diversity and evolvability offer the prospect of their use as a therapeutic solution. Reported are outcomes of customized phage therapy for patients with difficult-to-treat antimicrobial resistant infections. METHODS: We retrospectively assessed 12 cases of customized phage therapy from a phage production center. Phages were screened, purified, sequenced, characterized, and Food and Drug Administration-approved via the IND (investigational new drug) compassionate-care route. Outcomes were assessed as favorable or unfavorable by microbiologic and clinical standards. Infections were device-related or systemic. Other experiences such as time to treatment, antibiotic synergy, and immune responses were recorded. RESULTS: Fifty requests for phage therapy were received. Customized phages were generated for 12 patients. After treatment, 42% (5/12) of cases showed bacterial eradication and 58% (7/12) showed clinical improvement, with two-thirds of all cases (66%) showing favorable responses. No major adverse reactions were observed. Antibiotic-phage synergy in vitro was observed in most cases. Immunological neutralization of phages was reported in 5 cases. Several cases were complicated by secondary infections. Complete characterization of the phages (morphology, genomics, and activity) and their production (methods, sterility, and endotoxin tests) are reported. CONCLUSIONS: Customized phage production and therapy was safe and yielded favorable clinical or microbiological outcomes in two-thirds of cases. A center or pipeline dedicated to tailoring the phages against a patient's specific AMR bacterial infection may be a viable option where standard treatment has failed.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Green, S. I., Clark, J. R., Santos, H. H., Weesner, K., Salazar, K. C., Aslam, S., Campbell, J. W., Doernberg, S. B., Blodget, E., Morris, M. I., Suh, G. A., Obeid, K. M., Silveira, F. P., Filippov, A. A., Whiteson, K., Trautner, B. W., Terwilliger, A. L., & Maresso, A. W. (2023). A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clinical Infectious Diseases, 77(8), 1079–1091. https://doi.org/10.1093/cid/ciad335

MLA 9

Green, Sabrina I., et al. “A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.” Clinical Infectious Diseases, vol. 77, no. 8, 2023, pp. 1079–1091. https://doi.org/10.1093/cid/ciad335.

Chicago

Green, Sabrina I., Justin R. Clark, Haroldo Hernandez Santos, Kyle Weesner, Keiko Christine Salazar, Saima Aslam, J William Campbell, et al. 2023. “A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.” Clinical Infectious Diseases 77 (8): 1079–1091. https://doi.org/10.1093/cid/ciad335.

Harvard

Green, S. I. et al. (2023) ‘A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes’, Clinical Infectious Diseases, 77(8), pp. 1079–1091. doi:10.1093/cid/ciad335.

IEEE

S. I. Green et al., “A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes,” Clinical Infectious Diseases, vol. 77, no. 8, pp. 1079–1091, 2023, doi: 10.1093/cid/ciad335.

BibTeX

@article{green2023retrospective,
  title     = {{A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes}},
  author    = {Green, Sabrina I. and Clark, Justin R. and Santos, Haroldo Hernandez and Weesner, Kyle and Salazar, Keiko Christine and Aslam, Saima and Campbell, J William and Doernberg, Sarah B. and Blodget, Emily and Morris, Michele Ileana and Suh, Gina Ann and Obeid, Karam M. and Silveira, Fernanda P. and Filippov, Andrey A. and Whiteson, Katrine and Trautner, Barbara Wells and Terwilliger, Austen Lee and Maresso, Anthony William},
  journal   = {Clinical Infectious Diseases},
  year      = {2023},
  volume    = {77},
  number    = {8},
  pages     = {1079--1091},
  doi       = {10.1093/cid/ciad335},
  url       = {https://doi.org/10.1093/cid/ciad335}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202377
20242626
20253636
20264949

Its field-weighted citation impact is 11.39: it has been cited 11.39 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions

  • phage therapy
  • antimicrobial resistance
  • phage production
  • phage characterization
  • phage purification
  • endotoxin testing
  • antibiotic synergy
  • phage neutralization

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Green, S. I., Clark, J. R., Santos, H. H., Weesner, K., Salazar, K. C., Aslam, S., Campbell, J. W., Doernberg, S. B., Blodget, E., Morris, M. I., Suh, G. A., Obeid, K. M., Silveira, F. P., Filippov, A. A., Whiteson, K., Trautner, B. W., Terwilliger, A. L., & Maresso, A. W. (2023). A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clinical Infectious Diseases, 77(8), 1079–1091. https://doi.org/10.1093/cid/ciad335

How many times has this paper been cited?

118 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Clinical Infectious Diseases.

Who wrote this paper?

Sabrina I. Green, Justin R. Clark, Haroldo Hernandez Santos, Kyle Weesner, Keiko Christine Salazar, Saima Aslam, J William Campbell, Sarah B. Doernberg, Emily Blodget, Michele Ileana Morris, Gina Ann Suh, Karam M. Obeid and 6 more.

What is the DOI of this paper?

10.1093/cid/ciad335. The permanent link is https://doi.org/10.1093/cid/ciad335.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.